Literature DB >> 8140161

The effects of intraventricular injection of beta-endorphin on initial estrogen action to induce lordosis behavior.

M Torii1, K Kubo.   

Abstract

Ovariectomized female rats subcutaneously (SC) injected or intracerebrally implanted with estradiol benzoate (EB), and given progesterone SC were used as experimental animals to assess the effects of the beta-endorphin (beta-EP) neuronal system on lordosis behavior. In intraventricular (IV) injection of beta-EP at the onset of sc EB priming, the lordosis behavior was significantly (p < 0.001) facilitated. In contrast, the lordosis behavior was significantly (p < 0.001) inhibited by IV injection of naloxone, an opioid receptor antagonist. beta-EP facilitation of lordosis was observed exclusively within the initial stage of estrogen action. The behavior was significantly (p < 0.001) facilitated by IV injection of beta-EP given with an intracerebral implantation of crystalline EB into the septal-preoptic regions. However, the lordosis behavior was significantly (p < 0.001) inhibited by beta-EP when EB was implanted into the ventromedial hypothalamus. Animals receiving EB implants into the mesencephalic reticular formation were not affected by beta-EP. The present study suggests that the beta-EP neuronal system stimulates sexual receptivity through an action on the central nervous system in relation to the site of estrogen-initial activation to induce the lordosis reflex. The sites of beta-EP action may be the estrogen receptive septal-preoptic and hypothalamic regions; the former for facilitatory effect and the latter for inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140161     DOI: 10.1016/0031-9384(94)90024-8

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  13 in total

Review 1.  Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.

Authors:  Kevin Sinchak; Paul Micevych
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 2.  Temporal and concentration-dependent effects of oestradiol on neural pathways mediating sexual receptivity.

Authors:  P Micevych; K Sinchak
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 3.  Membrane estrogen receptors acting through metabotropic glutamate receptors: an emerging mechanism of estrogen action in brain.

Authors:  Paul E Micevych; Paul G Mermelstein
Journal:  Mol Neurobiol       Date:  2008-08-02       Impact factor: 5.590

Review 4.  Estradiol signaling in the regulation of reproduction and energy balance.

Authors:  Kevin Sinchak; Edward J Wagner
Journal:  Front Neuroendocrinol       Date:  2012-09-07       Impact factor: 8.606

5.  Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior.

Authors:  K Sinchak; P E Micevych
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

6.  Distribution of methionine and leucine enkephalin neurons within the social behavior circuitry of the male Syrian hamster brain.

Authors:  Avril Genene Holt; Sarah Winans Newman
Journal:  Brain Res       Date:  2004-12-24       Impact factor: 3.252

Review 7.  Extranuclear signaling by ovarian steroids in the regulation of sexual receptivity.

Authors:  Paul E Micevych; Kevin Sinchak
Journal:  Horm Behav       Date:  2018-05-18       Impact factor: 3.587

Review 8.  Nervous system physiology regulated by membrane estrogen receptors.

Authors:  Paul G Mermelstein; Paul E Micevych
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

9.  Modulation of the arcuate nucleus-medial preoptic nucleus lordosis regulating circuit: a role for GABAB receptors.

Authors:  Kevin Sinchak; Phoebe Dewing; Laura Ponce; Liliana Gomez; Amy Christensen; Max Berger; Paul Micevych
Journal:  Horm Behav       Date:  2013-06-10       Impact factor: 3.587

Review 10.  Membrane estradiol signaling in the brain.

Authors:  Paul Micevych; Reymundo Dominguez
Journal:  Front Neuroendocrinol       Date:  2009-05-04       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.